Arrowstreet Capital
GEN

Arrowstreet Capital’s Genesis Healthcare, Inc. GEN Stock Holding History

Arrowstreet Capital’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-85,790
Closed -$59K – 2624
2020
Q2 		$59K Buy
+85,790
New +$69K ﹤0.01% 2249
2017
Q3 		– Sell
-56,304
Closed -$98K – 1308
2017
Q2 		$98K Hold
56,304
– – ﹤0.01% 1025
2017
Q1 		$149K Buy
+56,304
New +$202K ﹤0.01% 1212

Other funds holding GEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Arrowstreet Capital's GEN Position: Q3 2020 in Review

Arrowstreet Capital sold out of Genesis Healthcare, Inc. (GEN) in Q3 2020, closing a stake of 85,790 shares — an estimated $59K sold.

Arrowstreet Capital first reported a position in GEN in Q1 2017 and held it in 3 quarters. The position peaked at $149K in Q1 2017. 55 funds tracked by Wall St. Rank hold GEN as of Q3 2020.

  • Arrowstreet Capital reported no remaining Genesis Healthcare, Inc. position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 85,790 Genesis Healthcare, Inc. shares in Q3 2020, an estimated $59K.
  • Arrowstreet Capital first reported a position in Genesis Healthcare, Inc. in Q1 2017 and held it in 3 quarters.
  • Arrowstreet Capital's Genesis Healthcare, Inc. position peaked at $149K in Q1 2017.
  • 55 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.